Skip to main content
  • Original article
  • Open access
  • Published:

Prevalence and effect of occult hepatitis C infection in patients with persistent liver enzyme elevation after achieving 24 weeks of sustained virological response

En

Abstract

Background

Despite achieving sustained virological response (SVR) of chronic hepatitis C infection, some of the treated patients have persistent elevations of transaminases. Occult hepatitis C infection (OCI) could be one of the causes.

Aim

The aim of this study was to detect OCI in peripheral blood mononuclear cells in patients who achieved 24-week SVR with persistent elevations of transaminases.

Methods

We included 998 naïve chronic HCV-infected patients who received treatment at our hospital. Patients with elevated liver enzymes after achieving SVR were determined. HCV RNA PCR in peripheral blood mononuclear cells was done for those patients (group 1) and was compared with a group with normal levels of enzymes, which was matched in age and sex (group 2).

Results

Nine hundred and sixty-five patients achieved SVR (96.69%). Seventy-four (7.7%) patients of them had elevated enzymes. OCI was detected in 14/74 (18.9%) patients of group 1, whereas it was seen in 4/67 (5.9%) in group 2. Cirrhosis, OCI, and obesity were associated with this enzymes elevation (P=0.005, 0.024, and <0.001). By multivariate analysis, none of these three parameters were independently associated with the enzyme elevation. The presence of OCI was not significantly associated with the presence of cirrhosis or obesity.

Conclusion

OCI is not infrequent in patients with persistent transaminase elevations despite obtaining 24 weeks of SVR. Liver cirrhosis, OCI, and obesity could have synergistic effects and should be considered as important risk factors of this persistent enzyme elevation.

References

  1. Ermis F, Senocak Tasci E. New treatment strategies for hepatitis C infection. World J Hepatol 2015; 7: 2100–2109.

    Article  Google Scholar 

  2. Bartolome J, Castillo I, Quiroga JA, Carreno V. Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection. J Med Virol 2016; 88: 268–274.

    Article  CAS  Google Scholar 

  3. Austria A, Wu GY. Occult hepatitis C virus infection: a review. J Clin Transl Hepatol 2018; 28: 155–160.

    Google Scholar 

  4. Welsch C, Efinger M, von Wagner M, Herrmann E, Zeuzem S, Welzel TM, Lange CM. Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response. PLoS One 2017; 12:e0171755.

    Article  Google Scholar 

  5. Chou R, Hartung D, Rahman B, Wasson N, Cottrell EB, Fu R. Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med 2013; 158: 114–123.

    Article  Google Scholar 

  6. Lin H, Chen X, Zhu S, Mao P, Zhu S, Liu Y et al. Prevalence of occult hepatitis C virus infection among blood donors in Jiangsu, China. Intervirology 2016; 59: 204–210.

    Article  CAS  Google Scholar 

  7. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernández N et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 2008; 19: 2288–2292.

    Article  Google Scholar 

  8. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJIII. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008; 47: 880–887.

    Article  Google Scholar 

  9. Sidharthan S, Kohli A, Sims Z, Nelson A, Osinusi A, Masur H, Kottilil S. Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy. Clin Infect Dis 2015; 15: 1743–1751.

    Article  Google Scholar 

  10. Van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F et al. Association between sustained virological and advanced hepatic fibrosis. JAMA 2012; 308:2584–2593.

    Article  Google Scholar 

  11. Poynard T, Moussalli J, Munteanu M, Thabut D, Lebray P, Rudler M et al. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. J Hepatol 2013; 59: 675–683.

    Article  CAS  Google Scholar 

  12. Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G. Hepatitis C and steatosis: a reappraisal. J Viral Hepat 2006; 13: 73–80.

    Article  CAS  Google Scholar 

  13. Castèra L, Hézode C, Roudot-Toraval F, Bastie A, Zafrani ES, Pawlotsky JM, Dhumeaux D. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52: 288–292.

    Article  Google Scholar 

  14. Schlevogt B, Deterding K, Port K, Siederdissen CHZ, Sollik L, Kirschner J et al. Interferon-free cure of chronic hepatitis C is associated with weight gain during long-term follow-up. Z Gastroenterol 2017; 55: 848–856.

    Article  Google Scholar 

  15. Elmasry S, Wadhwa S, Bang B-R, Cook L, Chopra S, Kanel G et al. Detection of occult hepatitis C virus infection in patients who achieved a sustained virological response to direct-acting antiviral agents for recurrent infection after liver transplantation. Gastroenterology 2017; 152: 550–553.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tamer R. Fouad MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohamed, A.A., Eljaky, A.M., Abdelsameea, E.M. et al. Prevalence and effect of occult hepatitis C infection in patients with persistent liver enzyme elevation after achieving 24 weeks of sustained virological response. Egypt J Intern Med 31, 288–291 (2019). https://doi.org/10.4103/ejim.ejim_24_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_24_19

Keywords